SureTrader Nadex Advertisement PGUS
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 3/29/2017 4:49:21 PM - Followers: 1320 - Board type: Free - Posts Today: 22

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#210271  Sticky Note Maxygen, slightly less than 3 months, back in rkrw 03/29/17 01:43:24 PM
#210268  Sticky Note RTTR -21%—(as it should be)—on last night’s easily-debunked PR. DewDiligence 03/29/17 11:26:06 AM
#210267  Sticky Note FDA approves Roche’s Ocrevus (ocrelizumab)—for both PPMS and RMS: DewDiligence 03/29/17 11:13:47 AM
#210250  Sticky Note VRTX +18%/AH on Tezacaftor/Kalydeco-combination data from two phase-3 trials: DewDiligence 03/28/17 07:06:33 PM
#210243  Sticky Note Interesting quote on pricing ($37k/yr) from a few biomaven0 03/28/17 04:14:13 PM
#210228  Sticky Note CARA CC notes: Actually, worth a listen for RockRat 03/28/17 02:00:59 PM
#210280   Inhalers are really hard - it's tricky to biomaven0 03/29/17 04:49:21 PM
#210279   It's hard to believe these multi billion dollar Bickema 03/29/17 04:26:23 PM
#210278   But Viagra spending stayed firm... biomaven0 03/29/17 04:15:21 PM
#210277   Hard Times! hptaxis 03/29/17 04:10:42 PM
#210276   Ominous trend for US-population stagnation? Cialis DTC advertising DewDiligence 03/29/17 03:38:11 PM
#210275   MYL -3% on CRL for generic Advair: DewDiligence 03/29/17 03:13:08 PM
#210274   MAXY continued to incur R&D costs through the DewDiligence 03/29/17 02:39:13 PM
#210273   MAXY--Just 4 years later. Where did all bladerunner1717 03/29/17 02:29:57 PM
#210272   MAXY’s platform was a bust—no drug based on DewDiligence 03/29/17 02:02:02 PM
#210271   Maxygen, slightly less than 3 months, back in rkrw 03/29/17 01:43:24 PM
#210270   (HALO)—FDA advisory panel backs subcutaneous formulation of Rituxan: DewDiligence 03/29/17 12:46:39 PM
#210269   Please see #msg-129899682 for sidenote on possible PFE-BMY deal. DewDiligence 03/29/17 11:29:37 AM
#210268   RTTR -21%—(as it should be)—on last night’s easily-debunked PR. DewDiligence 03/29/17 11:26:06 AM
#210267   FDA approves Roche’s Ocrevus (ocrelizumab)—for both PPMS and RMS: DewDiligence 03/29/17 11:13:47 AM
#210266   NVIV "InVivo Therapeutics Announces Seventh Patient Conversion in apljack 03/29/17 11:06:52 AM
#210265   BPMC diluting again. This must be a record. DewDiligence 03/29/17 10:52:33 AM
#210264   BPMC diluting again. This must be a record. linhdtu 03/29/17 10:39:04 AM
#210263   In addition to the useful CARA discussions here, biotech jim 03/29/17 10:17:10 AM
#210262   NTEC updates enrollment with Parkinson's drug bladerunner1717 03/29/17 09:54:43 AM
#210261   ACOR: Acorda Announces Long-Term Safety Data for CVT-301 haysaw 03/29/17 08:45:23 AM
#210260   GW Pharmaceuticals Announces Epidiolex® Receives Orphan Drug Designation puravida 03/29/17 07:43:13 AM
#210259   Could Pfizer Make Cash Bid for Bristol-Myers? http://www.barrons.com/articles/co Titan V 03/29/17 03:38:57 AM
#210258   You might have more ways to play CBIO nsomniyak 03/28/17 11:19:15 PM
#210257   I get exactly that for my off-label scrip north40000 03/28/17 09:52:19 PM
#210256   I believe the term "clinically meaningful" is also DewDiligence 03/28/17 08:25:45 PM
#210255   RockRat ..in the Renal space ...do you follow RockRat 03/28/17 08:18:16 PM
#210254   No doubt about it. Gonna get crushed scottsmith 03/28/17 08:14:43 PM
#210253   RTTR—The upward move at the end of the DewDiligence 03/28/17 08:09:49 PM
#210252   RockRat ..in the Renal space ...do you Whalatane 03/28/17 08:08:31 PM
#210251   You look at that AH chart? Crazy! scottsmith 03/28/17 07:57:28 PM
#210250   VRTX +18%/AH on Tezacaftor/Kalydeco-combination data from two phase-3 trials: DewDiligence 03/28/17 07:06:33 PM
#210249   RTTR reports (fudged) phase-2/3 data in lactose intolerance: DewDiligence 03/28/17 06:56:21 PM
#210248   For itching, don't dialysis patients receive Benadryl for RockRat 03/28/17 06:51:37 PM
#210247   AEZS implements $9M ATM facility: DewDiligence 03/28/17 05:14:22 PM
#210246   CARA Hogar ...direct from the dialysis floor Whalatane 03/28/17 05:07:36 PM
#210245   AKAO Robert Duggan strikes again Whalatane 03/28/17 04:57:20 PM
#210244   A lot of today's CC was devoted to DewDiligence 03/28/17 04:51:29 PM
#210243   Interesting quote on pricing ($37k/yr) from a few biomaven0 03/28/17 04:14:13 PM
#210242   SNY/REGN—Dupixent CC slides: DewDiligence 03/28/17 04:04:04 PM
#210241   PPHM already there with MSKCC, Ludwig and Parker. north40000 03/28/17 04:00:03 PM
#210240   For itching, don't dialysis patients receive Benadryl for hogar 03/28/17 03:58:31 PM
#210239   I find it odd too, going up so Titan V 03/28/17 03:54:22 PM
#210238   CBIO (+209%) Announces IND Approval in South Korea RockRat 03/28/17 03:37:44 PM
#210237   COCP—We had this conversation 1.5 years ago: #msg-117863227. DewDiligence 03/28/17 03:31:30 PM
#210236   Ray Schinazi seems to think that they have UHD 03/28/17 03:24:18 PM
#210235   Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and Titan V 03/28/17 02:56:05 PM
#210234   re CARA UP morbidity: Scratched areas get RockRat 03/28/17 02:50:12 PM
#210233   CARA. . Thx for the detail RockRat My wife Whalatane 03/28/17 02:28:03 PM
#210232   SNY/REGN CC today re Dupixent approval—4pm ET: DewDiligence 03/28/17 02:25:35 PM
#210231   RE CARA CC notes. It was pointed out RockRat 03/28/17 02:19:23 PM
PostSubject